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Lung cancer mortality essentially reflects – with a delay
of several decades – the pattern of smoking in various
populations, in the two sexes and in various age groups.1–3
Thus, the peak rates in lung cancer mortality for men in
northern Europe were reached in the late 1970s or early
1980s, in southern Europe in the late 1980s, whereas lung
cancer mortality was still rising – to the highest rates ever
registered – in most eastern European countries up to the
mid 1990s. In women, most trends were upwards, thus
leaving the impression of an expanding epidemic of lung
cancer in Europe.1–3
It is however important to look at recent changes in lung
cancer trends so as to understand future developments in
the tobacco-related lung cancer epidemic. Considering
the EU as a whole, male lung cancer mortality has been
declining since the late 1980s, and the 15% fall registered
between 1988 and 1998 (from 52 to 44/100,000 based on
the world standard population), is the equivalent of
saving 20,000 deaths in 1998. A similar fall in male lung
cancer mortality since the 1990s was observed in Russia,
although Russian rates remain over 40% higher than in
the EU (63/100,000 in 1998). In eastern Europe, a modest
fall (6%) has been observed only since 1995, and again
the rates of eastern European countries in the late 1990s
(59/100,000) are substantially higher than in the EU.
Among women the pattern is more complex, reflecting
differing trends in smoking among women in various
European countries.4–7 In the EU, female lung cancer
rates have risen to over 10/100,000 in the late 1990s. Over
the last few years, however, the slope of the rise has been
levelling off, suggesting that the female lung cancer epi-
demic in the EU as a whole may not reach the high levels
observed in North America,8–11 and in a few northern
(e.g., Denmark, the UK) or eastern European countries
(e.g., Hungary).1,2 Similar trends have also been observed
in middle-aged women, indicating a tendency for the rise
of female lung cancer mortality in the EU to level off in
the near future. In other eastern European countries the
upward trends in female lung cancer mortality have been
larger, approaching 11/100,000 in the late 1990s, but
again the changes in slopes have been relatively favour-
able over recent years, mostly in middle age. In Russia,
female lung cancer mortality rates have remained between
6 and 7/100,000 over the last two decades, and have
tended to decline over the last few years. Russian trends
in both sexes, however, are strongly influenced by cohort
effects due to historically low rates in generations who were
teenagers in 1945–1953, essentially because production of
consumer goods, such as cigarettes, had a lower priority in
the USSR than the post-war drive for industrialisation.12
Thus, recent trends in lung cancer in Europe indicate that
the epidemic has reached its peak and has started to level
off in men. Rates in females have been declining in the
Russian Federation, too, but are still rising in other areas,
though to a smaller extent than in the past. If recent
trends are maintained, and assuming some additional
impact of tobacco control in European women, overall
lung cancer rates in EU females may peak below
15/100,000 over the next decade.10,13 Rates for males may
fall below 40/100,000 within the next few years and,
assuming a further reduction in smoking, approach
30/100,000 by 2015, i.e. a rate similar to that registered
in the early 1950s.
The levelling of the lung cancer epidemic across Europe
essentially reflects the declining prevalence of tobacco
smoking in males over the last few decades, although
occupational, environmental and dietary aspects14 of lung
cancer may exert minor influences on these favourable
trends. However even greater efforts are needed finally to
bring to an end the tobacco-related lung cancer epidemic
in Europe.
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European Union enlargement
Will mental health be forgotten again?
ELIAS MOSSIALOS, ANANT MURTHY, DAVID MCDAID *
When the European Commission met in Copenhagen
in 1993 to outline a methodology for EU accession, many
eastern countries seemed far from meeting the necessary
political, economic, and legislative criteria. Much has
changed since the creation of the ‘Copenhagen criteria’
as the Council has now announced that eight nations in
eastern Europe – Estonia, Hungary, Poland, the Czech
Republic, Slovenia, Slovakia, Latvia and Lithuania – will
be ready for membership by 2004, with Romania and
Bulgaria ready by 2007. One topic yet to emerge however,
is the provision of mental health care and the status of
people with mental health problems in these countries.
Central and Eastern Europe face considerable challenges.
The overall burden of disease due to neuropsychiatric
disorders is estimated at 17.2% (DALYs), notably higher
than the world average (12.3%).1,2 Whilst these rankings
suggest that the prevalence of disorders is comparable to
that in western Europe, there is a consensus that both
treatments and the organisation of mental health services
have not kept up with reforms adopted in the west.3
Services have been influenced heavily by a historical
legacy of large psychiatric hospitals and social care homes,
a custodial rather than therapeutic attitude to patient
care, and a reliance on pharmacological interventions.
Psychiatry also has been subject to political abuse, with
incarceration in psychiatric institutions used as a means
of repression both in the former Soviet Union and
elsewhere in Eastern Europe. Since 1980 the Geneva
Initiative on Psychiatry, originally the International
Association on the Political Use of Psychiatry (IAPUP),
has led efforts within national and international
psychiatric organisations to eliminate such systematic
abuse. Community based care has been sparse and often
equated with outpatient or dispensary care. Moreover,
community social structures, including the role of the
family, were weakened first under the former soviet-style
system and later by the strain of economic transition. This
has led to a lack of support for people with severe mental
disorders outside the framework of institutionalised care,
further aggravated by widespread stigma, discrimination
and social exclusion.
Hierarchical systems of central planning limited the
responsiveness of mental health institutions,4 and for
several decades, psychiatry in the east was isolated from
western developments, access to journals, conferences,
and other modes of information exchange. Un-
fortunately, as described by the WHO in the 2001 World
Health Report, many of these features still characterise
these countries’ mental health care systems.2
Furthermore, poor conditions in psychiatric hospitals and
care homes have given rise to human rights concerns. For
example, the violation of rights documented in Hungarian
care homes included the restriction of patients’ move-
ments (despite no legal authority to detain), invasion of
privacy, inadequate communication facilities, ineffective
complaint and monitoring mechanisms, poor access to
medical treatment, and the use of outdated treatments.
Some care homes continued to use severely restricting
‘caged beds’, despite international condemnation of the
practice by disability rights groups and the Council of
Europe. In Bulgaria the continued use of unmodified electro
convulsive therapy has also been recently criticised.5
Inadequate legal services and protection extended to people
with mental health problems has drawn states into litiga-
tion before the European Court of Human rights.6
Moreover, as is the case in many countries throughout the
world, mental health services are poorly resourced. EU
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